🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Something old, something new: The marriage of PD-1 and IL-2 dlvr.it/SgmdwR

Check out our preview written by the amazing postdoc Brendan Horton on the very cool study by #doughanahan and Mélanie Tichet

Stefani Spranger and I wrote a preview for this month's issue of Immunity ! Mélanie Tichet , Doug Hanahan and colleagues find that fusing anti-PD-1 and an IL-2 variant overcome immunotherapy resistance in pancreatic cancer. Go cytokines! cell.com/immunity/fullt…

Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages dlvr.it/Sgsz7t

Improving the efficacy of an immunocytokine. Read our summary and interview with Mélanie Tichet 👉 ow.ly/SfoG50Mu1HJ . Aga EPFL Research Office Roche

Study co-led by Ludwig Oncology UNIL CHUV's Douglas Hanahan & Mélanie Tichet shows a new agent, PD1-IL2v, targets killer T cells in tumors, activates them & extends survival of mice with pancreatic cancer. Its effects are enhanced by anti-PD-L1 immunotherapy. bit.ly/3vUPGi4

Join us on 09 March for our next 'Meet the Author'webinar with Prof. Douglas Hanahan and Adnieszka Chryplewicz who will be discussing their most recent paper. Registration is FREE for EACR members: ➡️ ow.ly/rEYp50N1QKf

A fantastic speaker line up at the 7th Zurich Immuno-Oncology Symposium Unispital_USZ A full day with four sessions chaired by Patrick Roth, Markus G. Manz, Dominik Schneidawind and Felix Beuschlein

🎉👏Welcome Mélanie Tichet, our newly established FCI group leader #Tumorimmunology. Mélanie & her lab investigate #immunoregulatory mechanisms in the #tumormicroenvironment and resistance to therapy. More➡️georg-speyer-haus.de/en/staff/tiche…

So happy to see our research on brain metastasis and the tumor vasculature finally out in Cancer Cell! 😍🍾 Thanks to Johanna Joyce for your mentorship, to all the co-authors for your contributions and to EMBO and HFSP for funding my postdoctoral stage 🙂

#Weltkrebstag #WorldCancerDay #WorldCancerDay2024 The LOEWE-Centre Frankfurt Cancer Institute Goethe-Universität Paul-Ehrlich-Institut Max Planck Institute for Heart and Lung Research Georg-Speyer-Haus, BSD FFM is developing individual therapy concepts, which are based on a better understanding of the underlying molecular mechanisms.

ProLOEWE-News No. 1 - 2024 with many exciting topics including #FrankfurtCancerConference (frankfurtcancerconference.org) Abstract Submission is open!!

For expression of interest please DM! We are currently looking for a technical assistant to join our international team!

One of the great features of the #AACRtumorenviron24 conference is the short talks from junior/trainee members showcasing their excellent works. #AACR simge yücel from #EPFL